UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 120

Sortiert nach

Whole body periodic acceleration in normal and reduced mucociliary clearance of conscious sheep

PloS one, 2019-11, Vol.14 (11), p.e0224764-e0224764

2019

Link zum Volltext

Verfügbarkeit prüfen

The porcine lung as a potential model for cystic fibrosis

American journal of physiology. Lung cellular and molecular physiology, 2008-08, Vol.295 (2), p.L240-L263

2008

Link zum Volltext

Verfügbarkeit prüfen

Nonantibiotic macrolides prevent human neutrophil elastase-induced mucus stasis and airway surface liquid volume depletion

American journal of physiology. Lung cellular and molecular physiology, 2013-06, Vol.304 (11), p.L746-L756

2013

Link zum Volltext

Verfügbarkeit prüfen

Mucus accumulation in the lungs precedes structural changes and infection in children with cystic fibrosis

Science translational medicine, 2019-04, Vol.11 (486)

2019

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of second generation amiloride analogs as therapy for cystic fibrosis lung disease

The Journal of pharmacology and experimental therapeutics, 2004-12, Vol.311 (3), p.929

2004

Link zum Volltext

Verfügbarkeit prüfen

Losartan Rescues Inflammation-related Mucociliary Dysfunction in Relevant Models of Cystic Fibrosis

American journal of respiratory and critical care medicine, 2020-02, Vol.201 (3), p.313-324

2020

Link zum Volltext

Verfügbarkeit prüfen

SPX-101 Is a Novel Epithelial Sodium Channel-targeted Therapeutic for Cystic Fibrosis That Restores Mucus Transport

American journal of respiratory and critical care medicine, 2017-09, Vol.196 (6), p.734-744

2017

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of a SPLUNC1-derived peptide for the treatment of cystic fibrosis lung disease

American journal of physiology. Lung cellular and molecular physiology, 2018-01, Vol.314 (1), p.L192-L205

2018

Link zum Volltext

Verfügbarkeit prüfen

Comparative Effects of Salmeterol, Albuterol, and Ipratropium on Normal and Impaired Mucociliary Function in Sheep

Chest, 2005-11, Vol.128 (5), p.3743-3749

2005

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological properties of N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-4-[4-(2,3-dihydroxypropoxy)phenyl]butyl-guanidine methanesulfonate (552-02), a novel epithelial sodium channel blocker with potential clinical efficacy for cystic fibrosis lung disease

The Journal of pharmacology and experimental therapeutics, 2008-04, Vol.325 (1), p.77

2008

Link zum Volltext

Verfügbarkeit prüfen

Airway Responses to Aerosolized Brevetoxins in an Animal Model of Asthma

American journal of respiratory and critical care medicine, 2005-01, Vol.171 (1), p.26-34

2005

Link zum Volltext

Verfügbarkeit prüfen

Hyaluronan blocks porcine pancreatic elastase-induced mucociliary dysfunction in allergic sheep

Journal of applied physiology (1985), 2007-06, Vol.102 (6), p.2324-2331

2007

Link zum Volltext

Verfügbarkeit prüfen

Montelukast Prevents Antigen-induced Mucociliary Dysfunction in Sheep

American journal of respiratory and critical care medicine, 2002-12, Vol.166 (11), p.1457-1460

2002

Link zum Volltext

Verfügbarkeit prüfen

Mechanism of pyocyanin- and 1-hydroxyphenazine-induced lung neutrophilia in sheep airways

Journal of applied physiology (1985), 1998-12, Vol.85 (6), p.2298-2304

1998

Link zum Volltext

Verfügbarkeit prüfen

Selectin Blockade Prevents Antigen-induced Late Bronchial Responses and Airway Hyperresponsiveness in Allergic Sheep

American journal of respiratory and critical care medicine, 1999-04, Vol.159 (4), p.1205-1214

1999

Link zum Volltext

Verfügbarkeit prüfen

Budesonide affects allergic mucociliary dysfunction

Journal of applied physiology (1985), 1998-09, Vol.85 (3), p.1086-1091

1998

Link zum Volltext

Verfügbarkeit prüfen

Selectin blockade prevents antigen-induced late bronchial responses and airway hyperresponsiveness in allergic sheep

American journal of respiratory and critical care medicine, 1999-04, Vol.159 (4), p.1205-1214

1999

Link zum Volltext

Verfügbarkeit prüfen

The porcine lung as a potential model for cystic fibrosis

American journal of physiology. Lung cellular and molecular physiology, 2008, Vol.39 (2)

2008

Link zum Volltext

Verfügbarkeit prüfen

Effects of unilateral bronchoconstriction on distribution of aerosols in ovine airways

Journal of aerosol medicine, 2001-09, Vol.14 (3), p.369-375

2001

Link zum Volltext

Verfügbarkeit prüfen

Endothelin-1 depresses tracheal mucus velocity in ovine airways via ET-A receptors

American journal of respiratory and critical care medicine, 1996-08, Vol.154 (2 Pt 1), p.341

1996

Link zum Volltext

Verfügbarkeit prüfen

Delivery of nebulized budesonide liposomes to the respiratory tract of allergic sheep

Journal of aerosol medicine, 1997, Vol.10 (2), p.117-128

1997

Link zum Volltext

Verfügbarkeit prüfen

Polymorphisms in ACE, ACE2, AGTR1 genes and severity of COVID-19 disease

PloS one, 2022-02, Vol.17 (2), p.e0263140-e0263140

2022

Link zum Volltext

Verfügbarkeit prüfen

Genetics of feline hypertrophic cardiomyopathy

Clinical genetics, 2020-09, Vol.98 (3), p.203-214

2020

Link zum Volltext

Verfügbarkeit prüfen

The EP300/TP53 pathway, a suppressor of the Hippo and canonical WNT pathways, is activated in human hearts with arrhythmogenic cardiomyopathy in the absence of overt heart failure

Cardiovascular research, 2022-05, Vol.118 (6), p.1466-1478

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 120

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(97)
Mit Volltextzugriff
(112)

Publikationsform

Sprache

Englisch
(111)
Spanisch
(13)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Whole body periodic acceleration in normal and reduced mucociliary clearance of conscious sheep

The porcine lung as a potential model for cystic fibrosis

Nonantibiotic macrolides prevent human neutrophil elastase-induced mucus stasis and airway surface liquid volume depletion

Mucus accumulation in the lungs precedes structural changes and infection in children with cystic fibrosis

Evaluation of second generation amiloride analogs as therapy for cystic fibrosis lung disease

Losartan Rescues Inflammation-related Mucociliary Dysfunction in Relevant Models of Cystic Fibrosis

SPX-101 Is a Novel Epithelial Sodium Channel-targeted Therapeutic for Cystic Fibrosis That Restores Mucus Transport

Evaluation of a SPLUNC1-derived peptide for the treatment of cystic fibrosis lung disease

Comparative Effects of Salmeterol, Albuterol, and Ipratropium on Normal and Impaired Mucociliary Function in Sheep

Pharmacological properties of N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-4-[4-(2,3-dihydroxypropoxy)phenyl]butyl-guanidine methanesulfonate (552-02), a novel epithelial sodium channel blocker with potential clinical efficacy for cystic fibrosis lung disease

Airway Responses to Aerosolized Brevetoxins in an Animal Model of Asthma

Hyaluronan blocks porcine pancreatic elastase-induced mucociliary dysfunction in allergic sheep

Montelukast Prevents Antigen-induced Mucociliary Dysfunction in Sheep

Mechanism of pyocyanin- and 1-hydroxyphenazine-induced lung neutrophilia in sheep airways

Selectin Blockade Prevents Antigen-induced Late Bronchial Responses and Airway Hyperresponsiveness in Allergic Sheep

Budesonide affects allergic mucociliary dysfunction

Selectin blockade prevents antigen-induced late bronchial responses and airway hyperresponsiveness in allergic sheep

The porcine lung as a potential model for cystic fibrosis

Effects of unilateral bronchoconstriction on distribution of aerosols in ovine airways

Endothelin-1 depresses tracheal mucus velocity in ovine airways via ET-A receptors

Delivery of nebulized budesonide liposomes to the respiratory tract of allergic sheep

Polymorphisms in ACE, ACE2, AGTR1 genes and severity of COVID-19 disease

Mutations in the NOTCH pathway regulator MIB1 cause left ventricular noncompaction cardiomyopathy

Genetics of feline hypertrophic cardiomyopathy

The EP300/TP53 pathway, a suppressor of the Hippo and canonical WNT pathways, is activated in human hearts with arrhythmogenic cardiomyopathy in the absence of overt heart failure

Suchergebnisse filtern